Metraipolis › archive › dc_e2d622da575c
Discovery and development of a new oxazolidinone with reduced toxicity for the treatment of tuberculosis — Europe PMC PMID:41530381
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41530381
- DOI
- 10.1038/s41591-[numero omesso]-x
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T20:22:19.735Z
- SHA-256 of the archived text
30d1826dfef9a2cf9da5726b7161b38c701fb32f2a9f2534219c9b6cea4bc8a7- Stable URL of this page
https://metraipolis.com/documento/dc_e2d622da575c
How to cite
Discovery and development of a new oxazolidinone with reduced toxicity for the treatment of tuberculosis — Europe PMC PMID:41530381 — Europe PMC (en), https://europepmc.org/article/MED/41530381 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e2d622da575c (Metraipolis archive dc_e2d622da575c, sha256 30d1826dfef9a2cf9da5726b7161b38c701fb32f2a9f2534219c9b6cea4bc8a7)
BibTeX
@misc{dce2d622da575c,
title = {Discovery and development of a new oxazolidinone with reduced toxicity for the treatment of tuberculosis — Europe PMC PMID:41530381},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41530381},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e2d622da575c; sha256 30d1826dfef9a2cf9da5726b7161b38c701fb32f2a9f2534219c9b6cea4bc8a7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41530381. Agents can read the archived copy with the MCP tool read_document.